The rise of antimicrobial resistance (AMR) is a complex problem with far-reaching consequences for healthcare systems worldwide. As resistant bacteria and fungi evolve, the effectiveness of commonly used antibiotics diminishes, leading to the re-emergence of previously treatable infections as major health threats. A multifaceted approach is needed to combat AMR, including improving antibiotic stewardship, investing in diagnostics for better treatment guidance, and developing novel antimicrobials. Public health initiatives must focus on educating communities and promoting responsible antibiotic use. Addressing AMR also requires global cooperation to ensure equitable access to treatment while preventing the spread of resistance across borders. It is a challenge that demands urgent and coordinated action from all sectors of society.
Title : Pathogen-derived noncanonical epitopes: Are they valuable targets for novel vaccinations and shall we be concerned about autoimmune responses?
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Severe influenza and other related respiratory infection cases during Omicron era in Japan
Masafumi Seki, Saitama Medical University International Medical Center, Japan